The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of March 2017.

This report summarizes the use of pneumococcal conjugate vaccine (PCV) and impact evidence as of November 2016 in countries routinely using PCV10 or PCV13.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries asof December 2016.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of September 2016.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of June 2016..

This PowerPoint presentation contains figures and maps shown in the June 2016 VIEW-hub Report. 

The PowerPoint presentation contains the figures and maps used shown in the May 2016 VIEW-hub Report on Global Vaccine Introduction and Implementation. 

A strategic gap analysis of the amount of evidence generated from published and ongoing PCV impact studies in the context of routine immunizations globally as of March 2016. This report was compiled using data from VIEW-hub. 

A strategic gap analysis of the amount of evidence generated from published and ongoing PCV impact studies in the context of routine immunizations globally as of July 2015. This report was compiled using data from VIEW-hub.